Pınar Alarslan

Dr. Pınar Alarslan


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2018 in Gynecological Endocrinology
Verified
Journal Article
Closed access
MAMurat Alan
Murat Alan
BGBeril Gurlek
Beril Gurlek
AYAlpay Yilmaz
Alpay Yilmaz
MAMurat Aksit
Murat Aksit
BABehnaz Aslanipour
Behnaz Aslanipour
CTCuneyt Eftal Taner
Cuneyt Eftal Taner
Asprosin associated with insulin resistance is a newly discovered peptide hormone. The peptide promotes hepatic glucose production. Polycystic ovary syndrome (PCOS) is a metabolic disorder. Insulin resistance plays a vital role in the pathogenesis of the disease. The aim of this study was to discover the association between insulin resistance and asprosin in women with PCOS. We recruited 78 subjects with PCOS and 78 age-matched and body mass index (BMI)-matched controls into this cross-sectional study. Circulating asprosin levels were validated using ELISA method. We also determined metabolic and hormonal parameters of the involved subjects. We found that circulating asprosin levels were elevated in women with PCOS with respect to controls. Asprosin levels showed a positive correlation with insulin resistance, BMI, and free androgen index (FAI). Moreover, subjects with the highest tertile of asprosin levels represented increased odds of having PCOS as compared to those subjects with the lowest tertile asprosin levels. Increased asprosin levels resulted to high possibility of having PCOS risk associated with insulin resistance.

15 August 2016 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
OCOzlem Gursoy Calan
Ozlem Gursoy Calan
PAPınar Alarslan
Pınar Alarslan
PSPinar Yesil Senses
Pinar Yesil Senses
GKGokcen Unal Kocabas
Gokcen Unal Kocabas
EOEbru Ozden
Ebru Ozden
OBOktay Bilgir
Oktay Bilgir

11 March 2016 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
TKT. Kume
T. Kume
PAPınar Alarslan
Pınar Alarslan
OYO. Yilmaz
O. Yilmaz
GKG. U. Kocabas
G. U. Kocabas
PYP. Yesil
P. Yesil
OCO. G. Calan
O. G. Calan

1 February 2016 in Endocrine
Verified
Journal Article
Closed access
PDF file
PAPınar Alarslan
Pınar Alarslan
OYOzgur Yilmaz
Ozgur Yilmaz
TKTuncay Kume
Tuncay Kume
GKGokcen Unal Kocabas
Gokcen Unal Kocabas
PSPinar Yesil Senses
Pinar Yesil Senses
OCOzlem Gursoy Calan
Ozlem Gursoy Calan

2 December 2016 in Endocrine Research
Verified
Journal Article
Closed access
MBMerve Bicer
Merve Bicer
AGAslı Guler
Aslı Guler
GKGokcen Unal Kocabas
Gokcen Unal Kocabas
CICetin Imamoglu
Cetin Imamoglu
ABAli Baloglu
Ali Baloglu
PAPınar Alarslan
Pınar Alarslan
Purpose: Endocan is a proteoglycan secreted mainly from endothelial cells. It has been implicated that there is a link between endocan and endothelial dysfunction. Polycystic ovary syndrome (PCOS) is a reproductive and metabolic disease associated with increased risk of cardiovascular events. The aims of this study were to ascertain whether circulating endocan levels are altered in women with PCOS, and whether there is an association between endocan and carotid intima media thickness (cIMT). Materials and methods: This cross-sectional study included 80 women with PCOS and 80 age- and BMI-matched controls without PCOS. Circulating endocan levels were measured using ELISA. Metabolic, hormonal parameters and cIMT were determined. 2-h oral glucose tolerance test (2-h OGTT) was performed on all women. Results: Circulating endocan levels were significantly elevated in women with PCOS compared with controls (5.99 ± 2.37 vs. 3.66 ± 1.79 ng/ml, P < 0.001). Endocan levels positively correlated with BMI, homeostasis model assessment of insulin resistance (HOMA-IR), free androgen index (FAI), high-sensitivity C-reactive protein (hs-CRP), and cIMT in both PCOS and control groups. Endocan levels did not correlate with fasting blood glucose, 2-h OGTT, A1C and lipid parameters. Multiple linear regression analysis revealed that endocan is an independent predictor for cIMT (β = 0.128, 95% CI = 0.118–0.138, P = 0.011). Conclusions: Circulating endocan levels are significantly higher in women with PCOS and endocan is independently associated with cIMT. Elevated endocan levels can be a predictor of increased cardiovascular risk in PCOS subjects.

1 June 2019 in Endocrine
Verified
Journal Article
Closed access
PDF file
IDİsMail Demi̇r
İsMail Demi̇r
AGAslı Guler
Aslı Guler
PAPınar Alarslan
Pınar Alarslan
AIAhmet Murat Isil
Ahmet Murat Isil
OUOzge Ucman
Ozge Ucman
PAPınar Alarslan
Pınar Alarslan